The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.

It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for ...

After hours: September 20 at 7:59 PM EDT Loading Chart for ABBV ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

After hours: 20 September at 7:59 pm GMT-4 ...

To sign up for Becker's GI & Endoscopy E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you ...